NVNO
enVVeno Medical Corp
$11.11
+0.28 (+2.59%)
At close · Jul 2
Market Cap
$7.42M
Shares
667,669
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.11
Open$10.76
Day$10.76–11.20
52W$8.67–196.70
Avg vol 30d8K
Short int15K · 2.2% float · 1.9d
Short vol74%
Last earningsApr 29, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−25% below
+
Price vs 50-day avg
+4% above
◦
RSI (14)
56 · neutral
+
MACD trend
positive
−
52-week position
1% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $11 › 200d $15 — 200d above 50d
+
Institutional flow
+17 funds added
−
Insider flow
Net -$1.4K over 90 days · 100% sells
+
Short interest
2.21% of float · ▼ -78.9% MoM · 1.9 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
17 holders — 13F breadth
Fundamentals
Strong
−
Revenue growth
−83% Y/Y
+
Gross margin
597%, expanding
+
EPS growth
+26% Y/Y
−
Free cash flow
$-15.6M
+
Balance sheet
net cash $3.1M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−25% below
Bearish
Price vs 50-day avg
+4% above
Bullish
RSI (14)
56 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
1% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $11 › 200d $15 — 200d above 50d
Institutional flow
Accumulating
+17 funds added
Insider flow
Distributing
Net -$1.4K over 90 days · 100% sells
Short interest
Falling
2.21% of float · ▼ -78.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $9
Now $11 · 1%
52-wk high $197
vs 200-day avg -25%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| enVVe valve sizes | 3 | as of April 29, 2026 | — |
| first stage patients | 10 | first stage of the TAVVE study | — |
| second stage control arm patients | 55 | second stage of the study | — |
| second stage patients | 220 | second stage of the study | — |
| second stage patients receiving enVVe valve | 165 | second stage of the study | — |
| U.S. clinical sites | 40 | the TAVVE study | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVNO
this stock
enVVeno Medical Corp
|
$7.42M | -1.1% | -83.3% | — | 2.2% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVNO | +0.5% | +3.7% | -7.7% | +3.7% | -1.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -0.9% | +5.0% | -15.7% | +4.0% | -10.3% |